Clinical trial · no report yet · Phase not applicable
NCT05640843
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
- NCT05640843 ↗
- Recruiting
- Memorial Sloan Kettering Cancer Center
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| Bluesky threads | 2 | |
| X threads | 1 |
The trial
ClinicalTrials.gov- Official title
- A Randomized Placebo Controlled Study of a Plant-Based Dietary Versus Supplement Versus Placebo Intervention in Patients With Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) - The Nutrition Prevention (NUTRIVENTION-3) Study
- Phase
- Phase not applicable
- Status
- Recruiting
- Conditions
- Monoclonal Gammopathy of Undetermined Significance; Smoldering Multiple Myeloma
- Interventions
- Whole Foods Plant-based Diet; Algae Omega 3 + Curcumin; Placebo supplements
- Arms
- Daily Harvest weekly · Experimental
- Supplements · Experimental
- Placebo · Placebo comparator
- Enrollment
- 180 (estimated)
- Primary outcomes
- Stool microbiome diversity at 12 weeks
- Sponsor
- Memorial Sloan Kettering Cancer Center with Paula and Rodger Riney Foundation, Plantable, M and M labs, VeggieDoctor, Sabinsa pharmaceuticals, Daily Harvest
- Start
- Nov 29, 2022
- Primary completion
- Nov 2026 (estimated)
- Results posted
- No
- Registry record
- NCT05640843 · updated Apr 16, 2026